| Revenue | 38,294.49a | 31,681.26a |
| Cost of sales | -31,288.46a | -27,090.82a |
| Gross profit | 7,006.03a | 4,590.44a |
| Other income | 1,333.07a | 1,329.72a |
| Other gains and losses | -51.79a | -121.59a |
| Impairment losses under expected credit loss model, net of reversal | -0.1a | -22.31a |
| Selling and distribution expenses | -439.33a | -415.1a |
| Research and development expenditure | -2,924.11a | -2,566.48a |
| Administrative expenses | -1,399.23a | -1,009.9a |
| Share of results of associates | 118.38a | 22.52a |
| Finance costs | -499.38a | -449.15a |
| Profit before tax | 3,143.53a | 1,358.15a |
| Income tax expense | -366.51a | -207.83a |
| Profit for the year | 2,777.02a | 1,150.32a |
| Profit for the year attributable to | — | — |
| Owners of the Company | 2,699.16a | 1,099.42a |
| Non-controlling interests | 77.87a | 50.91a |